E10.21
Type 1 diabetes mellitus with diabetic nephropathy
Clinical Classification Guidelines
Inclusion Terms
- Type 1 diabetes mellitus with intercapillary glomerulosclerosis
- Type 1 diabetes mellitus with intracapillary glomerulonephrosis
- Type 1 diabetes mellitus with Kimmelstiel-Wilson disease
Medical Intelligence & Overview
Type 1 diabetes mellitus is a chronic condition characterized by the body's inability to produce insulin, a hormone essential for regulating blood sugar levels. When this condition is complicated by diabetic nephropathy, the kidneys become damaged due to prolonged high blood sugar levels. This guide provides an overview of what this diagnosis entails, including its causes, symptoms, diagnosis, and potential management options.
Causes & Symptoms
Clinical Causes: Autoimmune destruction of insulin-producing beta cells in the pancreas, leading to insulin deficiency Chronic high blood sugar levels damaging small blood vessels in the kidneys Genetic predisposition that increases susceptibility to kidney damage in individuals with Type 1 diabetes Prolonged uncontrolled blood glucose levels contributing to the development of diabetic nephropathy
Key Symptoms: Swelling in the legs, ankles, or feet due to fluid retention Foamy or frothy urine indicating protein loss Increased urination, especially at night Fatigue and weakness High blood pressure Loss of appetite and nausea Weight gain caused by fluid retention Changes in urine appearance or frequency
Diagnostic & Treatment
Diagnosis Path: The diagnosis of diabetic nephropathy in someone with Type 1 diabetes involves a combination of laboratory tests and clinical assessments: - **Urinalysis** to detect protein presence, especially albumin - **Blood tests** to evaluate kidney function, including serum creatinine and estimated glomerular filtration rate (eGFR) - **Blood pressure monitoring** to assess hypertension - **Diagnosis of diabetes history** confirming prolonged high blood sugar levels - **Periodic screening** for early signs of kidney damage, especially in individuals with longstanding diabetes - **Biopsy** may occasionally be performed to confirm intercapillary glomerulosclerosis or other specific glomerular changes such as Kimmelstiel-Wilson nodules.
Treatment Protocols: Management of Type 1 diabetes with diabetic nephropathy focuses on controlling blood sugar levels, protecting kidney function, and managing symptoms: - **Blood sugar control** via insulin therapy tailored to individual needs - **Blood pressure management** using antihypertensive medications, often ACE inhibitors or ARBs, which can help slow kidney damage - **Dietary modifications** emphasizing reduced salt and protein intake to lessen kidney workload - **Regular monitoring** of kidney function and protein excretion to track disease progression - **Lifestyle changes** such as maintaining a healthy weight, engaging in physical activity, and avoiding smoking - **Treatment of complications**, including anemia and electrolyte imbalances - **Dialysis or transplantation** in advanced stages where kidney failure occurs Early detection and comprehensive management are crucial in slowing the progression of diabetic nephropathy and maintaining quality of life.
Clinical Advice & FAQs
Billing Guidance
Is E10.21 a billable ICD-10 code?
Yes, E10.21 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E10.21?
Clinical documentation must specify the nature of Type 1 diabetes mellitus with diabetic nephropathy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
